ARTICLE | Company News
Symyx in catalyst deal with Dow
September 22, 2000 7:00 AM UTC
Combinatorial chemistry company SMMX and DOW will develop catalysts for use in manufacturing pharmaceutical intermediates. DOW will fund the research and will have exclusive rights to use resulting ca...